Acyclovir 400mg Tablet, 15-count bottles, Rx only, Packaged by Safecor Health, LLC. Woburn, MA 01801, NDC 0093894305
Published June 21, 2017 · Recall initiated: July 7, 2016
Summary
FDA records drug Class II recall D-0903-2017, published June 21, 2017 and initiated July 7, 2016. Recalling firm: Safecor Health, LLC; Status: Terminated; Reported quantity: 601 bottles; Lot: Lot # A25591, Exp. 02/22/2017. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CGMP Deviations
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Safecor Health, LLC
- Distributor
- MA and NY
- Lot
- Lot # A25591, Exp. 02/22/2017
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAMetoclopramide Tablets, USP, 5 mg, 100 Tablets per bottle, Rx Only, Manufactured for: Teva Pharmaceuticals,November 4, 2026
- FDAFluphenazine HCl Elixir, USP, 15 mg per 3 mL, Delivers: 10 mL, Oral Elixir, PAI, Alcohol 14% by volume, ForSeptember 23, 2026
- FDAFluphenazine HCl Elixir, USP, 2.5 mg per 5 mL, Delivers: 5 mL, Oral Elixir, PAI, Alcohol 14% by volume, ForSeptember 23, 2026
- FDAFluphenazine HCl Elixir, USP, 10 mg per 2 mL, Delivers: 10 mL, Oral Elixir, PAI, Alcohol 14% by volume, ForSeptember 23, 2026
- FDACalcium Carbonate 600mg/Vitamin D3 400 International Units tablets, 60-count bottles, Pk By Safecor HealthJune 21, 2017
- FDADoxycycline100mg Tablets, 14-count bottles, Rx only, Packaged By Safecor Health LLC Woburn, MA 01801, NDCJune 21, 2017
Questions about this recall
Was Acyclovir 400mg Tablet, 15-count bottles, Rx only, Packaged by Safecor Health, LLC. Woburn, MA 01801, NDC 0093894305 recalled?
Yes. FDA published recall D-0903-2017 on June 21, 2017. Reported hazard: CGMP Deviations
What should I do if I have this product?
Voluntary: Firm initiated · Letter